RSR-13
Sponsored By
NovoCure Trial
Please Click On The Above Banner For More Details
Braintumor Website


Editor's note: Enrollment in this trial is now complete. No new patients are being accepted. Results should be published in mid 1993.
.

Go to http://www.allos.com to read the results of the phase 2 trial and for more details.
Title: A Phase 3, Randomized, Open-Label, Comparative Study of Standard Whole Brain Radiation Therapy With or Without RSR13 in Patients With Brain Metastases
  • Canada
    • Jean-Philippe Mercier, Principal Investigator, Ph: 514-252-3425
      Hopital Maisonneuve-Rosemont
      Montreal, Quebec, Canada
    • Mitchell Liu, Principal Investigator, Ph: 604-581-2211
      Fraser Valley Cancer Centre
      Surrey, British Columbia, Canada
    • Siraj HU.S.A.in, Principal Investigator, Ph: 403-670-2013
      Tom Baker Cancer Centre
      Calgary, Alberta, Canada
    • Wilson Roa, Principal Investigator, Ph: 780-432-8374
      Cross Cancer Institute
      Edmonton, Alberta, Canada
    • Roy Ma, Principal Investigator, Ph: 604-877-6000
      Vancouver Cancer Centre
      Vancouver, British Columbia, Canada
    • P.K. Ganguly, Principal Investigator, Ph: 709-737-4227
      Newfoundland Cancer Center
      St. Johns, Newfoundland, Canada
    • Liam Mulroy, Principal Investigator, Ph: 902-473-6000
      Novia Scotia Cancer Centre
      Halifax, Nova Scotia, Canada
    • Dave Stewart, Principal Investigator, Ph: 613-247-3527
      Ottawa Regional Cancer Centre
      Ottawa, Ontario, Canada
    • Farrok Karsan, Principal Investigator, Ph: 705-522-6237
      Northeastern Ontario
      Sudbury, Ontario, Canada
    • Khalil Sultanem, Principal Investigator, Ph: 514-842-1231
      The Montreal General Hospital
      Montreal, Quebec, Canada
    • J-P Bahary, Principal Investigator, Ph: 514-281-6039
      CHUM-Pavillion Notre Dame
      Montreal, Quebec, Canada
    • Andre Fortin, Principal Investigator, Ph: 418-691-5151
      Hotel-Dieu de Quebec
      Quebec City, Quebec, Canada
    • Abdenour Nabid, Principal Investigator, Ph: 819-346-1110
      Site Fleurimont
      Sheerbrooke, Quebec, Canada
    • Tetteh Ago, Principal Investigator, Ph: 306-766-2288
      Allan Blair Cancer Centre
      Regina, Saskatchewan, Canada
  • U.S.A.
    • Alabama
      • Steven S. Rosenfeld, Principal Investigator, Ph: 205-934-1813
        The University of Alabama at Birmingham
        Birmingham, AL, U.S.A.
      • Gregory Cotter, Principal Investigator, Ph: 334-460-7160
        University of South Alabama
        Mobile, AL, U.S.A.
    • Arizona
      • C. Leland Rogers, Principal Investigator, Ph: 602-285-3000
        St. Joseph's Hospital and the Barrows Neurologic Institute
        Phoenix, AZ, U.S.A.
      • Baldassarre Dino Stea, Principal Investigator, Ph: 520-694-7236
        The University of Arizona Health Sciences Center
        Tucson, AZ, U.S.A.
    • California
      • David Irwin, Principal Investigator, Ph: 510-204-3428
        Alta Bates Comprehensive Cancer Center
        Berkeley, CA, U.S.A.
      • Ilkcan Cokgor, Principal Investigator, Ph: 415-925-5000
        Marin Oncology Associates, Inc.
        Greenbrae, CA, U.S.A.
      • Huan Giap, Principal Investigator, Ph: 858-554-2000
        Scripps Green Hospital
        La Jolla, CA, U.S.A.
      • Solomon Hamburg, Principal Investigator, Ph: 310-289-2840
        Tower Hematology/Oncology
        Los Angeles, CA, U.S.A.
      • Michael Shea, Principal Investigator, Ph: 949-760-5528
        Hoag Cancer Center
        Newport Beach, CA, U.S.A.
    • Colorado
      • Laurie Gaspar, Principal Investigator, Ph: 303-372-6888
        UCHSC
        Denver, CO, U.S.A.
    • Florida
      • Eduardo Fernandez, Principal Investigator, Ph: 305-674-7580
        Columbia Cancer Research Network of FL
        Aventura, FL, U.S.A.
      • Mohammad Jahanzeb, Principal Investigator, Ph: 561-883-7500
        Comprehensive Cancer Research Group
        Boca Raton, FL, U.S.A.
    • Kentucky
      • William Spanos, Principal Investigator, Ph: 502-852-7171
        University of Louisville
        Louisville, KY, U.S.A.
    • Louisiana
      • Troy Scroggins, Principal Investigator, Ph: 504-842-3440
        Ochsner Clinic
        New Orleans, LA, U.S.A.
    • Massachusetts
      • Sidney Kadish, Principal Investigator, Ph: 781-744-8780
        Lahey Medical Center
        Burlington, MA, U.S.A.
      • Irving D. Kaplan, Principal Investigator, Ph: 508-798-6078
        St. Vincent's Hospital
        Worcester, MA, U.S.A.
      • Shelagh McCauley, Principal Investigator, Ph: 508-856-5551
        U Mass Memorial Healthcare
        Worcester, MA, U.S.A.
    • Maryland
      • Joann C. Manning, Principal Investigator, Ph: 410-368-8620
        Clinical Research Center
        Baltimore, MD, U.S.A.
      • Jack Hong, Principal Investigator, Ph: 410-355-0868
        Harbor View Radiation Oncology Center
        Baltimore, MD, U.S.A.
      • Larry Kleinberg, Principal Investigator, Ph: 410-614-2597
        Johns Hopkins Hospital
        Baltimore, MD, U.S.A.
    • Michigan
      • Amr Aref, Principal Investigator, Ph: 313-343-3750
        St. John Hospital and Medical Center
        Detroit, MI, U.S.A.
    • New Jersey
      • Christopher Koprowski, Principal Investigator, Ph: 856-342-2300
        Cooper Hospital
        Camden, NJ, U.S.A.
      • Eli Finkelstein, Principal Investigator, Ph: 908-629-8393
        Trinitas Hospital
        Elizabeth, NJ, U.S.A.
      • Smitha Gollamudi, Principal Investigator, Ph: 732-923-6890
        Monmouth Medical Center
        Long Branch, NJ, U.S.A.
      • Joseph Fanelle, Principal Investigator, Ph: 856-825-3500
        South Jersey Hospital
        Millville, NJ, U.S.A.
      • Lawrence Coia, Principal Investigator, Ph: 732-557-8295
        Community Medical Center
        Toms River, NJ, U.S.A.
    • New York
      • Vernon King, Principal Investigator, Ph: 518-262-3368
        Albany Medical Center
        Albany, NY, U.S.A.
      • Hani L. Ashamalla, Principal Investigator, Ph: 718-780-3677
        New York Methodist Hospital
        Brooklyn, NY, U.S.A.
      • Laszlo Mechtler, Principal Investigator, Ph: 716-887-4058
        Dent Neurologic Institute
        Buffalo, NY, U.S.A.
      • David Sherr, Principal Investigator, Ph: 516-562-4815
        North Shore University Hospital
        Manhasset, NY, U.S.A.
    • North Carolina
      • Edward Shaw, Principal Investigator, Ph: 336-716-4981
        Wake Forest University
        Winston-Salem, NC, U.S.A.
    • Ohio
      • Mitchel Fromm, Principal Investigator, Ph: 330-384-6448
        Akron General Hospital
        Akron, OH, U.S.A.
      • William F. Demas, Principal Investigator, Ph: 330-375-3557
        SUMMA Health System Hospitals
        Akron, OH, U.S.A.
      • Ron Warnick, Principal Investigator, Ph: 513-558-3179
        Director of Surgical Neuro-Oncology
        Cincinnati, OH, U.S.A.
      • John Suh, Principal Investigator, Ph: 216-444-5574
        Cleveland Clinic Hospital
        Cleveland, OH, U.S.A.
      • John Grecula, Principal Investigator, Ph: 614-293-3244
        Ohio State University
        Columbus, OH, U.S.A.
    • Pennsylvania
      • Stephen Powers, Principal Investigator, Ph: 717-531-8807
        The Milton S. Hershey Medical Center
        Hershey, PA, U.S.A.
    • Tennessee
      • Furhan Yunus, Principal Investigator, Ph: 901-725-1785
        Boston Cancer Center
        Memphis, TN, U.S.A.
    • Texas
      • Pamela New, Principal Investigator, Ph: 210-617-5161
        The University of Texas
        San Antonio, TX, U.S.A.
    • Virginia
      • Paul Song, Principal Investigator, Ph: 703-698-3731
        Fairfax Hospital
        Falls Church, VA, U.S.A.
      • Brian Kavanagh, Principal Investigator, Ph: 804-828-7232
        Virginia Commonwealth University
        Richmond, VA, U.S.A.



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2014 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites